Log in
Enquire now
‌

US Patent 6861234 Method of epitope discovery

Patent 6861234 was granted and assigned to MannKind Corporation on March, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Patent Applicant
Loading...
1
Current Assignee
MannKind Corporation
MannKind Corporation
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
68612341
Patent Inventor Names
David C. Diamond1
John J. L. Simard1
Date of Patent
March 1, 2005
1
Patent Application Number
095610741
Date Filed
April 28, 2000
1
Patent Citations Received
‌
US Patent 11859015 Immunogenic WT-1 peptides and methods of use thereof
2
Patent Primary Examiner
‌
Patrick J. Nolan
1
Patent abstract

A method of epitope discovery comprising the step of selecting an epitope from a population of peptide fragments of an antigen associated with a target cell, wherein the fragments have a known or predicted affinity for a major histocompatibility complex class I receptor peptide binding cleft, wherein the epitope selected corresponds to a proteasome cleavage product of the target cell.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 6861234 Method of epitope discovery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.